MedPath

TEVA-NADOLOL

TEVA-NADOLOL

Discontinued
DIN Number

02126753

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02126753
AIG Number0113396003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AA12 NADOLOL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NADOLOLActive
Strength: 40 MG
Monograph: NADOLOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.